The 10-second takeaway
For the quarter ended March 31 (Q1), Orthofix International met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased slightly and GAAP earnings per share increased.
Margins improved across the board.
Orthofix International logged revenue of $143.1 million. The four analysts polled by S&P Capital IQ predicted a top line of $143.4 million on the same basis. GAAP reported sales were 2.9% higher than the prior-year quarter's $139.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.69. The five earnings estimates compiled by S&P Capital IQ anticipated $0.66 per share. GAAP EPS were $0.63 for Q1 against -$2.00 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 77.0%, 100 basis points better than the prior-year quarter. Operating margin was 15.4%, 110 basis points better than the prior-year quarter. Net margin was 8.4%, 3,410 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $148.6 million. On the bottom line, the average EPS estimate is $0.74.
Next year's average estimate for revenue is $602.9 million. The average EPS estimate is $3.04.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 120 members out of 128 rating the stock outperform, and eight members rating it underperform. Among 38 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 37 give Orthofix International a green thumbs-up, and one gives it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Orthofix International is outperform, with an average price target of $49.17.
The healthcare investing landscape is littered with also-rans and a few major winners. Is Orthofix International performing well enough for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will deliver amazing returns during the next few years. Click here for instant access to this free report.
- Add Orthofix International to My Watchlist.